For the Inventor, By the Inventor

Enter assignee name

Princeton, NJ, United States of America

Cytogen Corporation

USPTO Granted Patents = 34

CIPO Patents = 5

EPO Patents = 2

Trademarks = 4

Forward Citations = 2,212

Loading Chart...

Loading Chart...

42 inventors (with patents filed for the assignee):

Daniel J Coughlin (15 out of 19 patents)

Vernon L Alvarez (14 out of 17 patents)

Benjamin A Belinka, Jr (10 out of 14 patents)

4. John D Rodwell (9 out of 11 patents)

5. Thomas J McKearn (6 out of 8 patents)

6. Richard Wood (5 out of 5 patents)

7. Dana M Fowlkes (3 out of 30 patents)

8. Brian K Kay (3 out of 19 patents)

9. Byung Hee Jeon (3 out of 7 patents)

10. Robert D Radcliffe (3 out of 3 patents)

11. Julius S Horoszewicz (3 out of 3 patents)

12. Chyi Lee (3 out of 3 patents)

13. John W Goers (3 out of 3 patents)

14. Imelda Lambkin (2 out of 10 patents)

15. Gregorio Pirozzi (2 out of 2 patents)

34 patents: Sort by Forward Citations

1. 11789023 - Androgen receptor variant-based prostate cancer patient screening method (2023-10-17),

2. 11718882 - EML4-ALK gene mutation analysis method (2023-08-08),

3. 11513124 - Prostate-specific membrane antigen-based prostate cancer patient screening method (2022-11-29),

4. 7279548 - Identification and isolation of novel polypeptides having WW domains and methods of using same (2007-10-09),

5. 7223547 - Polypeptides having a functional domain of interest and methods of identifying and using same (2007-05-29),

6. 7135457 - Random peptides that bind to gastro-intestinal tract (GIT) transport receptors and related methods (2006-11-14),

7. 7053177 - Random peptides that bind to gastro-intestinal tract (GIT) transport receptors and related methods (2006-05-30),

8. 6015561 - Antigen binding peptides (abtides) from peptide libraries (2000-01-18),

9. 6011137 - Identification and isolation of novel polypeptides having WW domains and (2000-01-04),

10. 5942210 - Methods for lyoprotecting a macromolecule using tricine (1999-08-24),

11. 5885577 - Antigen binding peptides (abtides) from peptide libraries (1999-03-23),

12. 5763202 - Methods of detecting prostate carcinoma using a monoclonal antibody to a (1998-06-09),

13. 5609847 - Treatment methods using metal-binding targeted polypeptide constructs (1997-03-11),

14. 5593656 - Metal-binding targeted polypeptide constructs (1997-01-14),

15. 5585468 - Substituted thioureas as bifunctional chelators (1996-12-17),

Cytogen Corporation is a biopharmaceutical company specializing in the development and commercialization of innovative therapies to treat various cancers. Our team of scientists and researchers is dedicated to advancing the field of oncology and improving patient outcomes. With a focus on precision medicine and targeted therapies, Cytogen aims to provide personalized treatment options to patients worldwide. Visit our website to learn more about our cutting-edge research and development initiatives.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 9 2025

34 Patents

#32 in Princeton, NJ

#394 in New Jersey

#9,663 in US

#19,027 in the World

Princeton, NJ, United States of America

Cytogen Corporation

Forward Citations = 2,212

42 inventors:

Daniel J Coughlin (15 out of 19 patents)

Vernon L Alvarez (14 out of 17 patents)

Benjamin A Belinka, Jr (10 out of 14 patents)

4. John D Rodwell (9 out of 11 patents)

5. Thomas J McKearn (6 out of 8 patents)

Please report any incorrect information to support@idiyas.com

Loading…